EWTX
Edgewise Therapeutics Inc.
$15.10
+$0.84(+5.89%)
50
Overall
--
Value
50
Tech
--
Quality
Market Cap
$1.50B
Volume
886.08K
52W Range
$10.60 - $38.12
Target Price
$39.17
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||
| Operating Expenses | $43.2M | $71.7M | $114.4M | $158.8M | ||
| Research & Development | $32.2M | $54.0M | $90.9M | $127.0M | ||
| Research Expense | $32.2M | $54.0M | $90.9M | $127.0M | ||
| Selling, General & Administrative | $11.0M | $17.6M | $23.5M | $31.9M | ||
| General & Administrative Expenses | $11.0M | $17.6M | $23.5M | $31.9M | ||
| Salaries & Wages | -- | -- | $17.6M | $24.7M | ||
| Depreciation & Amortization | $272.0K | $368.0K | $1.6M | $2.1M | ||
| Depreciation & Amortization | $272.0K | $368.0K | $1.6M | $2.1M | ||
| Other Operating Expenses | $110.0K | -- | -- | -- | ||
| OPERATING INCOME | ||||||
| Operating income | $-43.2M | $-71.7M | $-114.4M | $-158.8M | ||
| EBITDA | $-42.5M | $-71.1M | $-98.4M | $-131.5M | ||
| NON-OPERATING ITEMS | ||||||
| Intinc | $402.0K | $4.0M | $14.2M | $25.0M | ||
| Net Non-Operating Interest Income/Expense | $402.0K | $4.0M | $14.2M | $25.0M | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-42.8M | $-71.7M | $-100.2M | $-133.8M | ||
| Pre-Tax Income | $-42.8M | $-67.6M | $-100.2M | $-133.8M | ||
| NET INCOME | ||||||
| Net Income | $-42.8M | $-67.6M | $-100.2M | $-133.8M | ||
| Net Income (Continuing Operations) | $-42.8M | $-67.6M | $-100.2M | $-133.8M | ||
| Net Income (Discontinued Operations) | $-42.8M | $-67.6M | $-100.2M | $-133.8M | ||
| Net Income (Common Stockholders) | $-42.8M | $-67.6M | $-100.2M | $-133.8M | ||
| Normalized Income | -- | -- | -- | $-132.5M | ||
| TOTALS | ||||||
| Total Expenses | $43.2M | $71.7M | $114.4M | $158.8M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $37.5M | $53.6M | $63.7M | $92.4M | ||
| Average Shares Outstanding (Diluted) | $37.5M | $53.6M | $63.7M | $92.4M | ||
| Shares Outstanding | $49.5M | $63.3M | $93.1M | $95.2M | ||
| Basic EPS | $-1.14 | $-1.26 | $-1.57 | $-1.45 | ||
| Basic EPS (Continuing Operations) | $-1.14 | $-1.26 | $-1.57 | $-1.45 | ||
| Diluted EPS | $-1.14 | $-1.26 | $-1.57 | $-1.45 | ||
| Diluted EPS (Continuing Operations) | $-1.14 | $-1.26 | $-1.57 | $-1.45 | ||
| OTHER METRICS | ||||||
| Other Gand A | $11.0M | $17.6M | $23.5M | $31.9M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EWTX | $15.10 | +5.9% | 886.08K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Edgewise Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW